XML 29 R18.htm IDEA: XBRL DOCUMENT
v3.20.2

SHARE-BASED COMPENSATION | 6 Months Ended
--- | ---
Jun. 28, 2020
Share-based Payment Arrangement [Abstract] |
Share-Based Compensation | SHARE-BASED COMPENSATION Stock Options and Restricted Stock For the thirteen week periods ended June 28, 2020 and June 30, 2019, the Company recognized $0.2 million of compensation expense related to stock awards. For the twenty-six week periods ended June 28, 2020 and June 30, 2019, the Company recognized $0.4 million and $0.5 million of compensation expense related to stock awards, respectively. Unamortized share-based compensation expense as of June 28, 2020 amounted to $1.3 million which is expected to be recognized over the next 2.4 years. A summary of stock option and restricted stock activity is presented as follows:
| Number of Shares |  | Weighted Average Exercise Price Per Share |  | Weighted Average Remaining Contractual Life |  | Total Intrinsic Value of Awards (in thousands)
Awards outstanding at December 29, 2019 | 582,845 |  |  | $ | 18.32 |  |  | 7.5 |  | $ | 2,793 |
Awards outstanding at June 28, 2020 | 582,845 |  |  | $ | 18.32 |  |  | 7.0 |  | $ | 343 |
Awards exercisable at December 29, 2019 | 313,645 |  |  | $ | 16.05 |  |  | 6.8 |  | $ | 1,991 |
Awards exercisable at June 28, 2020 | 340,995 |  |  | $ | 16.47 |  |  | 6.4 |  | $ | 158 |
|  | Number of Shares |  | Weighted Average Grant Date Fair Value
Nonvested outstanding at December 29, 2019 |  | 269,200 |  |  | $ | 20.96 |
Nonvested outstanding at June 28, 2020 |  | 241,850 |  |  | $ | 20.93 |
For the twenty-six week period ended June 30, 2019, the Company issued 9,298 shares of common stock upon the cashless exercise of 22,240 stock options. Included in awards outstanding are 18,000 and 27,000 shares of restricted stock (which vest equitably over a four year period), at a grant date price per share of $28.61, issued under the 2013 Plan as of June 28, 2020 and December 29, 2019, respectively. For the thirteen and twenty-six week periods ended June 28, 2020 and June 30, 2019, the Company recognized $0.1 million of compensation expense related to restricted stock. Warrant Activity For the thirteen and twenty-six week periods ended June 28, 2020 and June 30, 2019, the Company did not recognize compensation cost related to warrants. There was no unamortized stock compensation expense to be recognized as of June 28, 2020. A summary of warrant activity is presented as follows:
| Number of Shares |  | Weighted Average Exercise Price Per Share |  | Weighted Average Remaining Contractual Life |  | Total Intrinsic Value of Options (in thousands)
Warrants outstanding at December 29, 2019 | 64,482 |  |  | $ | 13.84 |  |  | 0.8 |  | $ | 473 |
Forfeited | (38,620) |  |  | $ | 11.85 |  |  |  |  |
Warrants outstanding at June 28, 2020 | 25,862 |  |  | $ | 16.80 |  |  | 0.9 |  | $ | — |
Warrants exercisable at December 29, 2019 | 64,482 |  |  | $ | 13.84 |  |  | 0.8 |  | $ | 473 |
Warrants exercisable at June 28, 2020 | 25,862 |  |  | $ | 16.80 |  |  | 0.9 |  | $ | — |
There were no nonvested warrants outstanding at June 28, 2020 and December 29, 2019. For the twenty-six week period ended June 30, 2019, the Company issued 423 shares of common stock upon the cashless exercise of 1,020 warrants. The intrinsic value in the tables above is the amount by which the market value of the underlying stock exceeded the exercise price of outstanding options or warrants, before applicable income taxes and represents the amount holders would have realized if all in-the-money options or warrants had been exercised on the last business day of the period indicated.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration